DIT-309

N/A

Report date: 2026/05/06 20:02:28

Base Information

Drug NameDIT-309
Drug Alias NameDIT309DIT-309
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionCD276 antigen modulatorsT lymphocyte replacements
TargetsCD276 antigen
Therapy Area/IndicationsSarcomaOsteosarcoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesTcelltech Inc
China Registration ClassN/A

Develop Information

Active CompaniesTcelltech Inc
Inactive CompaniesN/A
Active IndicationsSarcomaOsteosarcoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A